- Ownership hops held
- 32
An absent edge means not yet observed — never does not exist.
CG Oncology, Inc.
CG Oncology, Inc. — US company (sec:0001991792). UBO chain traced 32 hops, 14 owners. Every claim linked to its source.
Ownership resolves 32 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- CG Oncology, Inc.
None in current sources.
32-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on CG Oncology, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
14 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- Cui XiangminAlso holds roles at 11 other companies
- Aardvark Therapeutics, Inc.10% owner
- Nuvation Bio Inc.director
- BEYONDSPRING INC.tenpercentowner
- Decheng Capital Global Healthcare Fund (Master), LPAlso holds roles at 4 other companies
- Aardvark Therapeutics, Inc.10% owner
- BEYONDSPRING INC.tenpercentowner
- Aardvark Therapeutics, Inc.tenpercentowner
- Decheng Capital Global Healthcare GP, LLCAlso holds roles at 4 other companies
- Aardvark Therapeutics, Inc.10% owner
- BEYONDSPRING INC.tenpercentowner
- Aardvark Therapeutics, Inc.tenpercentowner
- Decheng Capital Global Life Sciences Fund IV, L.P.Also holds roles at 3 other companies
- Aardvark Therapeutics, Inc.10% owner
- Aardvark Therapeutics, Inc.tenpercentowner
- Equillium, Inc.tenpercentowner
- Decheng Capital Management IV (Cayman), LLCAlso holds roles at 3 other companies
- Aardvark Therapeutics, Inc.10% owner
- Aardvark Therapeutics, Inc.tenpercentowner
- Equillium, Inc.tenpercentowner
- Graf Susan EAlso holds roles at 4 other companies
- Aardvark Therapeutics, Inc.director
- FINCH THERAPEUTICS GROUP, INC.director
- EPIZYME, INC.officer
- PATTERSON JOSHUA F.Also holds roles at 2 other companies
- GAMIDA CELL LTD.officer
- AKCEA THERAPEUTICS, INC.officer
- POST LEONARD EAlso holds roles at 3 other companies
- uniQure N.V.director
- Fulgent Genetics, Inc.director
- PRAECIS PHARMACEUTICALS INCdirector
- ROCHE CORLEEN M.Also holds roles at 2 other companies
- IOVANCE BIOTHERAPEUTICS, INC.officer
- Immunome Inc.officer
- Rossi ChristinaAlso holds roles at 2 other companies
- Blueprint Medicines Corpofficer
- Xilio Therapeutics, Inc.director
14 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns CG Oncology, Inc.?
- What is CG Oncology, Inc.'s risk level?
- Where does CG Oncology, Inc. appear across sources?